MA45283A1 - Une composition de multivalent pneumococcal la protéine de polysaccaride-transporteur capsulaire se conjugue et utilisez de cela - Google Patents

Une composition de multivalent pneumococcal la protéine de polysaccaride-transporteur capsulaire se conjugue et utilisez de cela

Info

Publication number
MA45283A1
MA45283A1 MA45283A MA45283A MA45283A1 MA 45283 A1 MA45283 A1 MA 45283A1 MA 45283 A MA45283 A MA 45283A MA 45283 A MA45283 A MA 45283A MA 45283 A1 MA45283 A1 MA 45283A1
Authority
MA
Morocco
Prior art keywords
capsular
protein conjugates
transporter protein
pneumococcal polysaccharide
multivalent composition
Prior art date
Application number
MA45283A
Other languages
English (en)
Other versions
MA45283B1 (fr
Inventor
Tae Hyun Kim
Hoon Sung Jeh
Original Assignee
Lg Chemical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lg Chemical Ltd filed Critical Lg Chemical Ltd
Publication of MA45283A1 publication Critical patent/MA45283A1/fr
Publication of MA45283B1 publication Critical patent/MA45283B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention concerne une composition de vaccin comprenant 13 ou 14 types de conjugués de protéine de transport de polysaccharide capsulaire pour la prévention de maladies à pneumocoque et une composition immunogène pour streptococcus pneumoniae.
MA45283A 2016-09-06 2017-08-31 Une composition de multivalent pneumococcal la protéine de polysaccaride-transporteur capsulaire se conjugue et utilisez de cela MA45283B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20160114591 2016-09-06
PCT/KR2017/009569 WO2018048141A1 (fr) 2016-09-06 2017-08-31 Composition comprenant une protéine multivalent de transport de polysaccharide capsulaire et son utilisation

Publications (2)

Publication Number Publication Date
MA45283A1 true MA45283A1 (fr) 2019-06-28
MA45283B1 MA45283B1 (fr) 2021-05-31

Family

ID=61561397

Family Applications (1)

Application Number Title Priority Date Filing Date
MA45283A MA45283B1 (fr) 2016-09-06 2017-08-31 Une composition de multivalent pneumococcal la protéine de polysaccaride-transporteur capsulaire se conjugue et utilisez de cela

Country Status (12)

Country Link
KR (1) KR101991457B1 (fr)
BR (1) BR112019004303A2 (fr)
EA (1) EA201990451A1 (fr)
JO (1) JOP20190038B1 (fr)
MA (1) MA45283B1 (fr)
MX (1) MX2019002552A (fr)
MY (1) MY192792A (fr)
PH (1) PH12019500377B1 (fr)
SA (1) SA519401232B1 (fr)
TN (1) TN2019000064A1 (fr)
WO (1) WO2018048141A1 (fr)
ZA (1) ZA201901969B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210177957A1 (en) 2017-12-06 2021-06-17 Merck Sharp & Dohme Corp. Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
KR102486891B1 (ko) 2018-02-05 2023-01-10 사노피 파스퇴르 인코포레이티드 다가 폐렴구균성 다당류-단백질 접합체 조성물
KR20190121713A (ko) * 2018-04-18 2019-10-28 에스케이바이오사이언스(주) 스트렙토코커스 뉴모니애 협막 다당류 및 그의 면역원성 접합체
KR20240169145A (ko) 2018-12-19 2024-12-02 머크 샤프 앤드 돔 엘엘씨 스트렙토코쿠스 뉴모니아에 폴리사카라이드-단백질 접합체를 포함하는 조성물 및 그의 사용 방법
CN119317445A (zh) * 2022-05-11 2025-01-14 辉瑞公司 用于生产含有防腐剂的疫苗制剂的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69433341T2 (de) * 1993-09-22 2004-04-15 Henry M. Jackson Foundation For The Advancement Of Military Medicine Verfahren zur aktivierung von löslichem kohlenhydraten durch verwendung von neuen cyanylierungsreagenzien, zur herstellung von immunogenischen konstrukten
KR102378962B1 (ko) * 2005-04-08 2022-03-28 와이어쓰 엘엘씨 다가 폐렴구균 다당류-단백질 접합체 조성물
EP3170508B1 (fr) * 2010-06-04 2019-11-13 Wyeth LLC Formulations vaccinales
KR102057217B1 (ko) * 2012-06-20 2020-01-22 에스케이바이오사이언스 주식회사 다가 폐렴구균 다당류-단백질 접합체 조성물
CN103893751B (zh) * 2014-03-26 2016-04-20 天津康希诺生物技术有限公司 一种肺炎球菌多糖蛋白缀合疫苗及其制备方法
CN104069504B (zh) * 2014-05-11 2019-09-24 江苏康泰生物医学技术有限公司 一种增强多糖蛋白结合物免疫原性的方法

Also Published As

Publication number Publication date
SA519401232B1 (ar) 2022-10-23
MA45283B1 (fr) 2021-05-31
KR101991457B1 (ko) 2019-09-30
EA201990451A1 (ru) 2019-08-30
PH12019500377A1 (en) 2019-10-21
TN2019000064A1 (en) 2020-07-15
JOP20190038B1 (ar) 2023-09-17
PH12019500377B1 (en) 2024-05-15
MX2019002552A (es) 2019-07-01
JOP20190038A1 (ar) 2019-03-06
BR112019004303A2 (pt) 2019-05-28
KR20180027353A (ko) 2018-03-14
ZA201901969B (en) 2019-12-18
WO2018048141A1 (fr) 2018-03-15
MY192792A (en) 2022-09-09

Similar Documents

Publication Publication Date Title
MA45283A1 (fr) Une composition de multivalent pneumococcal la protéine de polysaccaride-transporteur capsulaire se conjugue et utilisez de cela
PH12021550318A1 (en) Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
CY1123783T1 (el) Antiσωμαta enanti-b7-h3 και συζευγματα αντισωματος φαρμακου
MX2020002559A (es) Polisacaridos neumococicos y su uso en conjugados de polisacarido inmunogenico con proteina transportadora.
EP3712178A4 (fr) Anticorps anti-her2 ou fragment de liaison à l'antigène de celui-ci, et récepteur antigénique chimérique le comprenant
BR112020004471A8 (pt) Polissacarídeos pneumocócicos e uso dos mesmos em conjugados imunogênicos polissacarídeo-proteína carreadora
PH12018500037A1 (en) Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
EP3668539A4 (fr) Protéines de liaison d'antigène ciblant des antigènes partagés
MX2020002556A (es) Polisacaridos neumococicos y su uso en conjugados de polisacarido inmunogenico con proteina transportadora.
EP3589314A4 (fr) Amélioration de l'immunogénicité de conjugués de polysaccharide de streptococcus pneumoniae et de protéine
EP4286000A3 (fr) Polysaccharides capsulaires de streptococcus pneumoniae et leurs conjugués
MX2016003621A (es) Vacunas sinteticas libres de proteina y peptido contra streptococcus pneumoniae tipo 3.
CO2021007863A2 (es) Vacuna conjugada polisacárido-proteína neumocócica multivalente
WO2018183182A8 (fr) Procédés et compositions pour la réduction d'immunogénicité
BR112015016817A8 (pt) métodos para derivar um sacarídeo, para conjugar um derivado de sacarídeo e para incitar uma resposta imune em um mamífero, derivado de sacarídeo, conjugado de um derivado de sacarídeo, composição farmacêutica, e, uso de um conjugado ou composição farmacêutica
MX2020008454A (es) Composicion inmunogenica que comprende antigenos estafilococicos.
MX2022001937A (es) Composicion inmunogenica.
AR114693A1 (es) Vacunas contra infecciones intraabdominales
HK1224585A1 (en) Protein and peptide-free synthetic vaccines against streptococcus pneumoniae type 3